Warby Parker WRBY
NYSE WRBY
$27.44 -0.02 (-0.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Warby Parker (WRBY) Net Income towards Common Stockholders (2020 - 2026)

Warby Parker's (WRBY) quarterly Net Income towards Common Stockholders came in at $3.2 million in Q1 2026, down 8.5% YoY from $3.5 million in Q1 2025, and up 153.39% on a QoQ basis from -$6.0 million in Q4 2025.

Warby Parker (WRBY) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Warby Parker (WRBY) has 7 years of Net Income towards Common Stockholders data on file, last reported at $3.2 million in Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 8.5% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 109.45% YoY) and the FY2025 annual result came in at $1.6 million, up 108.05% from the prior year.
  • Net Income towards Common Stockholders improved to $3.2 million in Q1 2026, from -$6.0 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $5.9 million in Q3 2025 to a low of -$34.1 million in Q1 2022.
  • A 5-year average of -$11.1 million and a median of -$6.9 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 2030.65% — and 2025, when it soared 244.25%.
  • Tracing WRBY's Net Income towards Common Stockholders over 5 years: stood at -$20.3 million in 2022, then climbed by 5.95% to -$19.0 million in 2023, then soared by 63.76% to -$6.9 million in 2024, then climbed by 13.78% to -$6.0 million in 2025, then soared by 153.39% to $3.2 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $3.2 million (Q1 2026), -$6.0 million (Q4 2025), and $5.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 378.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 383.43 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 139.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 147.90 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 93.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -77.90 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 126.00 Mn
10 Warby Parker 3.41 Bn 3.12 Bn 136.46 Mn 4.64 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.64 Mn
Mar 31, 2026 3.18 Mn
Dec 31, 2025 -5.95 Mn
Sep 30, 2025 5.87 Mn
Jun 30, 2025 -1.75 Mn
Mar 31, 2025 3.47 Mn
Dec 31, 2024 -6.90 Mn
Sep 30, 2024 -4.07 Mn
Jun 30, 2024 -6.76 Mn
Mar 31, 2024 -2.68 Mn
Dec 31, 2023 -19.05 Mn
Sep 30, 2023 -17.41 Mn
Jun 30, 2023 -15.93 Mn
Mar 31, 2023 -10.81 Mn
Dec 31, 2022 -20.25 Mn
Sep 30, 2022 -23.84 Mn
Jun 30, 2022 -32.17 Mn
Mar 31, 2022 -34.13 Mn
Dec 31, 2021 -45.90 Mn
Sep 30, 2021 -91.07 Mn